McKesson, US58155Q1031

McKesson stock: UBS raises target for McKesson stock to USD 1,200.00

Published on 10/20/2026 at 16:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson will report second-quarter fiscal 2027 results on November 4, 2026. McKesson stock costs EUR 904.20 on October 20, 2026.

UBS target and earnings date

  • UBS lifted its McKesson target from USD 1,080.00 to USD 1,200.00 on October 16, 2026.
  • First-quarter fiscal 2027 revenue reached USD 105.38 billion, up 7.70 percent year over year.
  • McKesson stock costs EUR 904.20 at Lang & Schwarz on October 20, 2026 at 4:38 p.m. CEST.
  • Second-quarter fiscal 2027 results are scheduled for November 4, 2026.
Pop-Art-Comic-Szene einer Apothekenübergabe visualisiert farbenfroh das Kerngeschäft von McKesson Corporation ISIN US58155Q1031 heiter und freundlich, Illustration mit AI erstellt.

McKesson Corporation (ISIN US58155Q1031) became the subject of a higher UBS valuation on October 16, 2026, when the bank lifted its price target from USD 1,080.00 to USD 1,200.00 while maintaining a Buy rating, MarketScreener reported. McKesson's euro price stood at EUR 904.20 at Lang & Schwarz on October 20, 2026 at 4:38 p.m. CEST.

Quarterly revenue reached USD 105.38 billion

McKesson's first-quarter fiscal 2027 revenue reached USD 105.38 billion for the period ended June 30, 2026, compared with USD 103.74 billion expected by analysts. Adjusted earnings per share rose 20.00 percent year over year to USD 9.93, while management raised fiscal 2027 adjusted earnings-per-share guidance to USD 44.20-45.00 from USD 43.80-44.60, Yahoo Finance reported on October 9, 2026.

Share price sits near its yearly high

The NYSE quote was USD 1,019.29 at 10:50 a.m. EDT on October 20, 2026, with a market capitalization of USD 118.8 billion and a price-to-earnings ratio of 27.25. McKesson's 52-week range was USD 723.68 to USD 1,024.47, placing the quote 0.51 percent below the high. The stock had gained 23.18 percent since the start of 2026 by the October 19 close.

Valuation meets a November earnings date

UBS's USD 1,200.00 target is 17.74 percent above the NYSE quote of USD 1,019.29, using both values in US dollars. The next scheduled catalyst is McKesson's second-quarter fiscal 2027 report on November 4, 2026, after the market close, followed by a conference call at 4:30 p.m. ET, McKesson announced on September 23, 2026.

What does the target imply?

The higher UBS target contrasts with the modest gap between the current NYSE quote and the recent yearly high. For investors, the November report will provide the next company-specific test of the USD 44.20-45.00 adjusted earnings-per-share outlook and the specialty-care expansion strategy.

Stock price and upcoming results

McKesson's euro quote was EUR 904.20 at Lang & Schwarz on October 20, 2026 at 4:38 p.m. CEST. On the NYSE, McKesson was trading at USD 1,019.29 on October 20, 2026 at 10:50 a.m. EDT.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.

McKesson stock facts

  • Company: McKesson Corporation
  • ISIN: US58155Q1031
  • Ticker: MCK
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 20, 2026, 4:38 p.m. CEST): EUR 904.20
  • Market capitalization: USD 118.8 billion (as of October 20, 2026)
  • 52-week range: USD 723.68-1,024.47 (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical Distribution
  • Next earnings date: November 4, 2026

Market context: Market report S&P 500.

More news and analyses on McKesson stock

Disclaimer...
en | US58155Q1031 | MCKESSON | boerse | 70375268 | bgmi